Using multiplexed immunofluorescence to quantitatively analyze myeloid derived suppressor cells (MDSCs) in relation to tertiary lymphoid structures (TLS) in bladder cancer
Literature
Read More
Identification of lung cancer mutational signatures and tumor drivers associated with specific bimodal PD-L1/TMB status
Literature
Read More
Mendelian randomization identifies FLCN expression as a mediator of diabetic retinopathy
Literature
Read More
NeoGenomics Reports Revenue Growth of 20% to Record $125 Million in the Third Quarter
Press Release
Read More
Clinical utility of TP53 mutations (TP53m) dynamic monitoring in circulating tumor DNA (ctDNA) in patients (pts) with high-grade ovarian carcinomas (HGOC)
Literature
Read More
NeoGenomics Announces Plans to Expand Global Footprint in Pharma Services by Opening Clinical Research Laboratory in Suzhou, China
Press Release
Read More